Upadacitinib for Recalcitrant Extragenital Morphea and Lichen Sclerosus Overlap: A Case Report

Authors

• Taha F. Rasul, HCA HealthcareFollow
• Christian E. Hemmerich, HCA HealthcareFollow
• Benjamin R. Cooper, HCA HealthcareFollow
• Lily Tehrani
• Karthik Krishnamurthy, HCA HealthcareFollow

Division

South Atlantic

Hospital

Orange Park Medical Center

Document Type

Case Report

Publication Date

6-25-2026

Keywords

Janus kinase inhibitor, lichen sclerosus, morphea, overlap, treatment-resistant, upadacitinib

Disciplines

Dermatology | Medicine and Health Sciences | Skin and Connective Tissue Diseases

Abstract

No abstract available

Publisher or Conference

JAAD Case Reports

Recommended Citation

Rasul T, Hemmerich CE, Cooper B, Tehrani L, Krishnamurthy K. Upadacitinib for recalcitrant extragenital morphea and lichen sclerosus overlap: A case report. JAAD Case Rep. 2026;75:85-88. Published 2026 Jun 25. doi:10.1016/j.jdcr.2026.06.043